NCT00219349View on ClinicalTrials.gov

Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)

PHASE4CompletedINTERVENTIONAL

Enrollment

25

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Generalized Anxiety Disorder

Interventions

BEHAVIORAL

Cognitive Behavioral Therapy

14 weekly sessions of individualized CBT

DRUG

escitalopram

10-20 mg per day for 12 weeks

Trial Locations (1)

10032

Anxiety Disorders Clinic, New York State Psychiatric Institute, New York

Sponsors

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

New York State Psychiatric Institute

OTHER